| When: Tuesday, 11/5/2024, 1:30 pm - 2:30 pm |
| Where: Henry B. Gonzalez Convention Center-207 |
| Credits: 1 CME_Physicians Credit |
| Credits: 1 CME_OtherProfessions Credit |
Description: Discover how genetics, nutrition, socioeconomic status, and health care delivery imact the intricate relationship between obesity and 13 different cancers. Explore how recent innovations in obesity therapeutics may prove effective in certain obesity-related cancers, but may also have long-term risks. Immerse yourself in this informative session to uncover the fascinating role of GLP-1's in obesity and its associated cancers.
|
| Delivery Mechanism: Live In-Person |
| Keyword: Co-morbidities: Cancer; Co-morbidities: Diabetes; Pathophysiology: Metabolic Stress |
Track: Track 1: Metabolism and Integrative Physiology
|
|
Speakers:
 | Justin C. Brown, PhD | Moderate Q&A | 2:15 pm - 2:30 pm |  | Stephen Hursting, PhD, MPH, RD | Q&A | 2:15 pm - 2:30 pm | | Stephen Hursting, PhD, MPH, RD | Breaking the Obesity-Cancer Link: Impact of Incretin Mimetics | 1:30 pm - 2:15 pm | | Justin C. Brown, PhD | Session Chair | |
|
|
| Learning Objectives: |
| 1. Apply the latest recommendations for evaluation and treatment; tailor intervention strategies based on patient characteristics such as age or metabolic or behavioral phenotype; understand the differences between weight loss and weight loss maintenance. |
| 2. Understand the evidence-based science regarding neuroendocrine, environmental, endocrine, microbiota and/or cognitive behavioral mechanisms regulating energy balance and body weight. Apply that knowledge to develop and implement treatment options for adults and pediatric patients with overweight, obesity or obesity-related co-morbidities. |
| 4. Apply lessons learned about the impact of nutrition and obesity initiatives and policies to reduce health disparities and stigmatization of individuals with obesity. |
|
|